tight-junction remodeling is the actionable driver in: Blood-brain barrier permeability changes as early biomarkers for neurodegeneration

Target: tight-junction remodeling Composite Score: 0.750 Price: $0.50 Citation Quality: Pending neurodegeneration Status: active
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
🏆 ChallengeValidate tight-junction remodeling as early biomarker for neurodegener$400 bounty →
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
6
Citations
2
Debates
6
Supporting
1
Opposing
Quality Report Card click to collapse
B+
Composite: 0.750
Top 10% of 1510 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
F Mech. Plausibility 15% 0.00 Top 50%
B+ Evidence Strength 15% 0.74 Top 18%
B+ Novelty 12% 0.76 Top 33%
B Feasibility 12% 0.68 Top 37%
A Impact 12% 0.82 Top 21%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
B Reproducibility 5% 0.65 Top 35%
Evidence
6 supporting | 1 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.75
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

Blood-brain barrier permeability changes as early biomarkers for neurodegeneration

What blood-brain barrier permeability changes serve as early biomarkers for neurodegeneration, and what CSF/blood biomarker panels can detect them?

→ View full analysis & debate transcript

Description

The gap can be tested by treating tight-junction remodeling as an upstream driver rather than a passive correlate. If true, perturbing dynamic contrast MRI should shift CSF/serum albumin ratio before downstream neurodegeneration markers change.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Tight Junction Complex
CLDN5 and OCLN Assembly"] B["Paracellular Barrier Integrity
Selective Permeability"] C["Inflammatory Mediators
VEGF TNF and IL-1beta"] D["ZO-1 Scaffold Dissociation
TJ Protein Phosphorylation"] E["Claudin-5 Internalization
Lysosomal Degradation Route"] F["BBB Leakage
Albumin and Fibrinogen Entry"] G["Neuroinflammation
Peripheral Immune Cell Infiltration"] A --> B C -.->|"disrupts"| A C --> D D --> E E --> F F --> G style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style C fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8 style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.00 (15%) Evidence 0.74 (15%) Novelty 0.76 (12%) Feasibility 0.68 (12%) Impact 0.82 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.65 (5%) KG Connect 0.50 (8%) 0.750 composite
7 citations 5 with PMID 5 medium Validation: 0% 6 supporting / 1 opposing
For (6)
5
No opposing evidence
(1) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
2
1
1
MECH 3CLIN 2GENE 1EPID 1
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
A/T/N: An unbiased descriptive classification sche…SupportingCLINNeurology MEDIUM20160.33PMID:27371494-
Retinal neurodegeneration and brain MRI markers: t…SupportingCLINNeurobiol Aging MEDIUM20170.33PMID:28974335-
Impact of brain aging and neurodegeneration on cog…SupportingMECHCurr Opin Neuro… MEDIUM20130.33PMID:24184970-
Glymphatic system clears extracellular tau and pro…SupportingMECHJ Exp Med MEDIUM20220.33PMID:35212707-
Tau protein aggregation is associated with cellula…SupportingGENEAging Cell MEDIUM20180.59PMID:30126037-
No claimSupportingMECHfour_round_gap_…-----
causal direction requires longitudinal perturbatio…OpposingEPIDskeptic_round-----
Legacy Card View — expandable citation cards

Supporting Evidence 6

No claim
four_round_gap_debate
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. MEDIUM
Neurology · 2016 · PMID:27371494 · Q:0.33
Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. MEDIUM
Neurobiol Aging · 2017 · PMID:28974335 · Q:0.33
Impact of brain aging and neurodegeneration on cognition: evidence from MRI. MEDIUM
Curr Opin Neurol · 2013 · PMID:24184970 · Q:0.33
Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration. MEDIUM
J Exp Med · 2022 · PMID:35212707 · Q:0.33
Tau protein aggregation is associated with cellular senescence in the brain. MEDIUM
Aging Cell · 2018 · PMID:30126037 · Q:0.59

Opposing Evidence 1

causal direction requires longitudinal perturbation
skeptic_round
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Hypothesis Formal | 3 rounds | 2026-04-26 | View Analysis

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (10)

Impact of brain aging and neurodegeneration on cognition: evidence from MRI.
Current opinion in neurology (2014) · PMID:24184970
No extracted figures yet
No extracted figures yet
No extracted figures yet
Retinal neurodegeneration and brain MRI markers: the Rotterdam Study.
Neurobiology of aging (2018) · PMID:28974335
No extracted figures yet
No extracted figures yet
Multiscale dynamics of tight junction remodeling.
J Cell Sci (2019) · PMID:31754042
No extracted figures yet
No extracted figures yet
No extracted figures yet
Blood-brain barrier biomarkers.
Advances in clinical chemistry (2024) · PMID:38797540
No extracted figures yet
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
31.7th percentile (747 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
6

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.800

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

KG Entities (7)

endothelial transcytosisgap-20260426-001501h-gap-5c6cec3e-m1h-gap-5c6cec3e-m2h-gap-5c6cec3e-m3pericyte stresstight-junction remodeling

Related Hypotheses

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
Score: 0.990 | neurodegeneration
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
Score: 0.921 | neurodegeneration
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.920 | neurodegeneration
HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM Transition
Score: 0.919 | neurodegeneration
CYP46A1 Overexpression Gene Therapy
Score: 0.919 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions (2)

2 total 0 confirmed 0 falsified
IF tight-junction remodeling is an upstream BBB driver, THEN reducing claudin-5/occludin integrity in brain endothelial cultures will increase albumin permeability by >=50% before neuronal injury-conditioned media markers rise.
pending conf: 0.63
Expected outcome: Endothelial barrier model shows >=50% albumin permeability increase before neuronal injury markers exceed baseline by 10%.
Falsified by: Permeability increase is <15% or occurs only after neuronal injury-conditioned markers rise.
Method: Human iPSC BBB-on-chip with tight-junction perturbation, albumin flux, and downstream neuronal co-culture readouts.
IF dynamic contrast MRI captures tight-junction-driven BBB change, THEN DCE-MRI permeability will rise >=10% at least 12 months before CSF/serum albumin ratio or NfL rises in at-risk older adults.
pending conf: 0.55
Expected outcome: Regional DCE-MRI Ktrans increases >=10% before albumin ratio or NfL threshold crossing.
Falsified by: Ktrans does not precede fluid biomarker change or changes by <3%.
Method: At-risk human longitudinal imaging cohort with annual DCE-MRI, CSF/serum albumin ratio, and plasma NfL.

Knowledge Subgraph (6 edges)

associated with (3)

gap-20260426-001501h-gap-5c6cec3e-m1gap-20260426-001501h-gap-5c6cec3e-m2gap-20260426-001501h-gap-5c6cec3e-m3

involves (3)

h-gap-5c6cec3e-m1tight-junction remodelingh-gap-5c6cec3e-m2pericyte stressh-gap-5c6cec3e-m3endothelial transcytosis

Mechanism Pathway for tight-junction remodeling

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    gap_20260426_001501["gap-20260426-001501"] -->|associated with| h_gap_5c6cec3e_m1["h-gap-5c6cec3e-m1"]
    h_gap_5c6cec3e_m1_1["h-gap-5c6cec3e-m1"] -->|involves| tight_junction_remodeling["tight-junction remodeling"]
    gap_20260426_001501_2["gap-20260426-001501"] -->|associated with| h_gap_5c6cec3e_m2["h-gap-5c6cec3e-m2"]
    h_gap_5c6cec3e_m2_3["h-gap-5c6cec3e-m2"] -->|involves| pericyte_stress["pericyte stress"]
    gap_20260426_001501_4["gap-20260426-001501"] -->|associated with| h_gap_5c6cec3e_m3["h-gap-5c6cec3e-m3"]
    h_gap_5c6cec3e_m3_5["h-gap-5c6cec3e-m3"] -->|involves| endothelial_transcytosis["endothelial transcytosis"]
    style gap_20260426_001501 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m1 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m1_1 fill:#4fc3f7,stroke:#333,color:#000
    style tight_junction_remodeling fill:#81c784,stroke:#333,color:#000
    style gap_20260426_001501_2 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m2 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m2_3 fill:#4fc3f7,stroke:#333,color:#000
    style pericyte_stress fill:#81c784,stroke:#333,color:#000
    style gap_20260426_001501_4 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m3 fill:#4fc3f7,stroke:#333,color:#000
    style h_gap_5c6cec3e_m3_5 fill:#4fc3f7,stroke:#333,color:#000
    style endothelial_transcytosis fill:#81c784,stroke:#333,color:#000

3D Protein Structure

🧬 TIGHT-JUNCTION — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for TIGHT-JUNCTION structures...
Querying Protein Data Bank API

Source Analysis

Blood-brain barrier permeability changes as early biomarkers for neurodegeneration

neurodegeneration | 2026-04-26 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (2)

plasma GFAP separates causal from compensatory states in: Blood-brain
Score: 0.74 · plasma GFAP
endothelial transcytosis defines the therapeutic window for: Blood-bra
Score: 0.72 · endothelial transcytosis
→ View all analysis hypotheses